Compass Therapeutics Stock Price History
| CMPX Stock | USD 3.00 0.15 4.76% |
Below is the normalized historical share price chart for Compass Therapeutics extending back to September 16, 1988. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Compass Therapeutics stands at 3.00, as last reported on the 21st of July, with the highest price reaching 3.22 and the lowest price hitting 2.97 during the day.
If you're considering investing in Compass Stock, it is important to understand the factors that can impact its price. Compass Therapeutics appears to be very risky, given 3 months investment horizon. Compass Therapeutics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19 % return per unit of risk over the last 3 months. By analyzing Compass Therapeutics' technical indicators, you can evaluate if the expected return of 0.75% is justified by implied risk. Please makes use of Compass Therapeutics' Mean Deviation of 2.95, risk adjusted performance of 0.2227, and Downside Deviation of 3.82 to double-check if our risk estimates are consistent with your expectations. Total Stockholder Equity is likely to drop to about 67.9 M in 2025. Common Stock Total Equity is likely to drop to about 11.1 K in 2025. Price To Sales Ratio is likely to drop to 187.11 in 2025. Price Earnings Ratio is likely to drop to -4.23 in 2025. Compass Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of April 2021 | 200 Day MA 2.1613 | 50 Day MA 2.3944 | Beta 1.217 |
Sharpe Ratio = 0.1911
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMPX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.91 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.75 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Compass Therapeutics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compass Therapeutics by adding it to a well-diversified portfolio.
Price Book 3.7618 | Enterprise Value Ebitda (8.92) | Price Sales 488.0541 | Shares Float 88.9 M | Wall Street Target Price 13.2222 |
Compass Therapeutics Stock Price History Chart
There are several ways to analyze Compass Stock price data. The simplest method is using a basic Compass candlestick price chart, which shows Compass Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 17, 2025 | 3.15 |
| Lowest Price | May 6, 2025 | 1.69 |
Compass Therapeutics July 21, 2025 Stock Price Synopsis
Various analyses of Compass Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Compass Stock. It can be used to describe the percentage change in the price of Compass Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Compass Stock.| Compass Therapeutics Price Daily Balance Of Power | (0.60) | |
| Compass Therapeutics Price Rate Of Daily Change | 0.95 | |
| Compass Therapeutics Price Action Indicator | (0.17) |
Compass Therapeutics July 21, 2025 Stock Price Analysis
Compass Stock Price History Data
The price series of Compass Therapeutics for the period between Tue, Apr 22, 2025 and Mon, Jul 21, 2025 has a statistical range of 1.46 with a coefficient of variation of 17.19. The prices are distributed with arithmetic mean of 2.26. The median price for the last 90 days is 2.14.| Open | High | Low | Close | Volume | ||
07/21/2025 | 3.15 | 3.22 | 2.97 | 3.00 | ||
07/21/2025 | 3.15 | 3.22 | 2.97 | 3.00 | ||
07/18/2025 | 3.20 | 3.22 | 2.97 | 3.00 | 662,436 | |
07/17/2025 | 3.15 | 3.27 | 3.10 | 3.15 | 1,242,725 | |
07/16/2025 | 3.02 | 3.18 | 2.97 | 3.13 | 722,101 | |
| 07/15/2025 | 2.97 | 3.08 | 2.86 | 2.98 | 1,114,363 | |
07/14/2025 | 2.66 | 3.00 | 2.66 | 2.92 | 906,937 | |
07/11/2025 | 2.82 | 2.84 | 2.64 | 2.70 | 1,009,514 | |
07/10/2025 | 2.75 | 2.89 | 2.74 | 2.85 | 905,563 | |
07/09/2025 | 2.64 | 2.78 | 2.64 | 2.74 | 598,424 | |
07/08/2025 | 2.65 | 2.70 | 2.62 | 2.65 | 319,868 | |
07/07/2025 | 2.78 | 2.80 | 2.63 | 2.64 | 536,459 | |
07/03/2025 | 2.65 | 2.87 | 2.61 | 2.78 | 794,726 | |
07/02/2025 | 2.55 | 2.80 | 2.55 | 2.62 | 779,441 | |
07/01/2025 | 2.67 | 2.67 | 2.50 | 2.58 | 611,596 | |
| 06/30/2025 | 2.58 | 2.68 | 2.55 | 2.60 | 445,907 | |
06/27/2025 | 2.61 | 2.71 | 2.52 | 2.56 | 3,011,071 | |
06/26/2025 | 2.68 | 2.69 | 2.53 | 2.60 | 734,276 | |
06/25/2025 | 2.62 | 2.76 | 2.59 | 2.69 | 781,112 | |
06/24/2025 | 2.58 | 2.65 | 2.50 | 2.62 | 522,776 | |
| 06/23/2025 | 2.37 | 2.57 | 2.32 | 2.54 | 683,669 | |
06/20/2025 | 2.44 | 2.44 | 2.29 | 2.40 | 1,260,027 | |
06/18/2025 | 2.18 | 2.44 | 2.18 | 2.38 | 765,606 | |
06/17/2025 | 2.38 | 2.47 | 2.17 | 2.19 | 798,188 | |
06/16/2025 | 2.48 | 2.49 | 2.36 | 2.37 | 569,631 | |
06/13/2025 | 2.39 | 2.42 | 2.28 | 2.41 | 746,533 | |
06/12/2025 | 2.41 | 2.51 | 2.36 | 2.41 | 443,831 | |
06/11/2025 | 2.54 | 2.55 | 2.42 | 2.43 | 477,791 | |
06/10/2025 | 2.59 | 2.64 | 2.50 | 2.51 | 964,493 | |
06/09/2025 | 2.54 | 2.74 | 2.49 | 2.57 | 1,421,322 | |
06/06/2025 | 2.42 | 2.55 | 2.40 | 2.50 | 2,032,161 | |
06/05/2025 | 2.18 | 2.36 | 2.12 | 2.36 | 759,723 | |
06/04/2025 | 2.24 | 2.26 | 2.15 | 2.17 | 1,440,469 | |
06/03/2025 | 2.15 | 2.25 | 2.12 | 2.14 | 714,971 | |
06/02/2025 | 2.10 | 2.26 | 2.08 | 2.15 | 765,128 | |
05/30/2025 | 2.10 | 2.17 | 2.06 | 2.10 | 411,161 | |
05/29/2025 | 2.10 | 2.17 | 2.09 | 2.12 | 464,494 | |
| 05/28/2025 | 2.11 | 2.23 | 2.09 | 2.10 | 492,884 | |
05/27/2025 | 2.14 | 2.17 | 2.07 | 2.11 | 668,126 | |
05/23/2025 | 2.05 | 2.12 | 2.04 | 2.09 | 530,372 | |
05/22/2025 | 2.03 | 2.13 | 2.02 | 2.10 | 299,521 | |
05/21/2025 | 2.10 | 2.13 | 2.03 | 2.06 | 387,346 | |
05/20/2025 | 2.13 | 2.22 | 2.09 | 2.10 | 534,241 | |
05/19/2025 | 2.06 | 2.21 | 2.06 | 2.11 | 597,002 | |
05/16/2025 | 2.04 | 2.13 | 2.00 | 2.10 | 1,104,625 | |
05/15/2025 | 1.99 | 2.08 | 1.95 | 2.02 | 650,791 | |
| 05/14/2025 | 2.00 | 2.01 | 1.95 | 2.00 | 1,313,996 | |
05/13/2025 | 2.00 | 2.08 | 1.84 | 2.00 | 1,103,502 | |
05/12/2025 | 1.84 | 2.02 | 1.84 | 2.01 | 1,153,402 | |
| 05/09/2025 | 1.81 | 1.83 | 1.67 | 1.82 | 1,642,624 | |
| 05/08/2025 | 1.68 | 1.81 | 1.67 | 1.78 | 611,128 | |
05/07/2025 | 1.70 | 1.79 | 1.67 | 1.76 | 1,504,007 | |
| 05/06/2025 | 1.81 | 1.85 | 1.67 | 1.69 | 803,358 | |
05/05/2025 | 1.87 | 1.95 | 1.84 | 1.86 | 1,073,249 | |
05/02/2025 | 1.85 | 1.94 | 1.84 | 1.89 | 733,420 | |
05/01/2025 | 1.87 | 1.90 | 1.79 | 1.82 | 503,249 | |
04/30/2025 | 1.81 | 1.90 | 1.80 | 1.86 | 482,278 | |
04/29/2025 | 1.89 | 1.93 | 1.83 | 1.84 | 801,604 | |
| 04/28/2025 | 1.94 | 1.97 | 1.86 | 1.90 | 553,490 | |
04/25/2025 | 2.11 | 2.15 | 1.91 | 1.94 | 878,114 | |
04/24/2025 | 2.08 | 2.16 | 1.97 | 2.12 | 877,097 |
About Compass Therapeutics Stock history
Compass Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Compass is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Compass Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Compass Therapeutics stock prices may prove useful in developing a viable investing in Compass Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 137.1 M | 85.7 M | |
| Net Loss | -35.3 M | -37.1 M |
Compass Therapeutics Quarterly Net Working Capital |
|
Compass Therapeutics Stock Technical Analysis
Compass Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Compass Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Compass Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Compass Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Compass to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2227 | |||
| Jensen Alpha | 0.6726 | |||
| Total Risk Alpha | 0.3524 | |||
| Sortino Ratio | 0.2052 | |||
| Treynor Ratio | 0.4933 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.